Related Experiment Video
Updated: Jun 16, 2026

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153
1Basic Neurosciences Division, Biomedical Research Foundation of the Academy of Athens, Soranou Efesiou 4, Athens 11527, Greece. edoxakis@bioacademy.gr
Abstract:
Genetic and biochemical studies have established a central role for alpha-synuclein accumulation in the pathogenesis of Parkinson disease. Here, two microRNAs, namely mir-7 and mir-153, have been identified to regulate alpha-synuclein levels post-transcriptionally. These microRNAs bind specifically to the 3'-untranslated region of alpha-synuclein and down-regulate its mRNA and protein levels, with their effect being additive. They are expressed predominantly in the brain with a pattern that mirrors synuclein expression in different tissues as well as during neuronal development, indicating that they play a tuning role in the amount of alpha-synuclein produced. Overexpression of mir-7 and mir-153 significantly reduces endogenous alpha-synuclein levels, whereas inhibition of mir-7 and mir-153 enhances translation of a luciferase construct bearing the alpha-synuclein 3'-untranslated region in primary neurons. These findings reveal a significant additional mechanism by which alpha-synuclein is regulated and point toward new therapeutic regimes for lowering endogenous alpha-synuclein levels in patients with familial or sporadic Parkinson disease.
Insights
Two microRNAs, mir-7 and mir-153, regulate alpha-synuclein levels post-transcriptionally. This discovery offers new therapeutic strategies for Parkinson disease by lowering alpha-synuclein in the brain.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Alpha-synuclein accumulation is central to Parkinson disease pathogenesis.
- Post-transcriptional regulation of alpha-synuclein is crucial for neuronal health.
Purpose of the Study:
- To identify novel regulators of alpha-synuclein.
- To explore microRNA-mediated control of alpha-synuclein expression.
- To investigate potential therapeutic targets for Parkinson disease.
Main Methods:
- Identification of microRNAs targeting alpha-synuclein mRNA.
- Analysis of microRNA binding to the 3'-untranslated region of alpha-synuclein.
- Experimental manipulation (overexpression and inhibition) of mir-7 and mir-153 in neuronal cells.
- Luciferase reporter assays to confirm microRNA-mediated translational repression.
Main Results:
- Mir-7 and mir-153 were identified as key regulators of alpha-synuclein.
- These microRNAs bind to the alpha-synuclein 3'-untranslated region, reducing mRNA and protein levels additively.
- Mir-7 and mir-153 are predominantly expressed in the brain, correlating with synuclein expression patterns.
- Overexpression of mir-7/mir-153 decreased endogenous alpha-synuclein; inhibition increased its translation.
Conclusions:
- Mir-7 and mir-153 represent a significant mechanism for regulating alpha-synuclein levels.
- These microRNAs offer potential therapeutic targets for reducing alpha-synuclein in Parkinson disease.
- Findings open new avenues for treating familial and sporadic Parkinson disease.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

